Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Histology independent drug development - Is this the future for cancer drugs?
Billingham L, Brown L, Framke T, Greystoke A, Hovig E, Mathur S, Page P, Pean E, Barjesteh van Waalwijk van Doorn-Khosrovani S, Vonk R, Wissink S, Zander H, Plummer R. Billingham L, et al. Among authors: zander h. Cancer Treat Rev. 2024 Feb;123:102674. doi: 10.1016/j.ctrv.2023.102674. Epub 2023 Dec 23. Cancer Treat Rev. 2024. PMID: 38176220 Free article. Review.
Biomarker-Driven Developments in the Context of the New Regulatory Framework for Companion Diagnostics in the European Union.
Verbaanderd C, Trullás Jimeno A, Engelbergs J, Zander H, Reischl I, Moreno Oliver A, Vamvakas S, Vleminckx C, Bouygues C, Girard T, Day F, Frias Z. Verbaanderd C, et al. Among authors: zander h. Clin Pharmacol Ther. 2023 Aug;114(2):316-324. doi: 10.1002/cpt.2928. Epub 2023 May 25. Clin Pharmacol Ther. 2023. PMID: 37132507 Review.
The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.
Trullas A, Delgado J, Genazzani A, Mueller-Berghaus J, Migali C, Müller-Egert S, Zander H, Enzmann H, Pignatti F. Trullas A, et al. Among authors: zander h. ESMO Open. 2021 Jun;6(3):100145. doi: 10.1016/j.esmoop.2021.100145. Epub 2021 Apr 30. ESMO Open. 2021. PMID: 33940347 Free PMC article. Review.
The European Medicines Agency review of the initial application of atezolizumab and the role of PD-L1 expression as biomarker for checkpoint inhibitors.
Araujo-Fernandez I, Delgado J, Moscetti L, Sarac SB, Zander H, Mueller-Egert S, Dunder K, Pean E, Bergmann L, Enzmann H, Pignatti F. Araujo-Fernandez I, et al. Among authors: zander h. ESMO Open. 2021 Feb;6(1):100008. doi: 10.1016/j.esmoop.2020.100008. Epub 2020 Dec 16. ESMO Open. 2021. PMID: 33399074 Free PMC article. Review.
[Checkpoint inhibitors for cancer therapy].
Zander H, Müller-Egert S, Zwiewka M, Groß S, van Zandbergen G, Engelbergs J. Zander H, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Nov;63(11):1322-1330. doi: 10.1007/s00103-020-03221-9. Epub 2020 Oct 1. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 33001218 Free PMC article. Review. German.
157 results